Integer (ITGR) Bank of America Global Healthcare Conference 2026 summary

Market trends and positioning

• Outsourcing in med tech manufacturing is increasing, driven by OEMs' focus on next-generation therapies and regulatory hurdles.

• Strong engineering, technical expertise, and global manufacturing scale support a leading industry position.

• Deep integration with major OEMs and a diversified portfolio underpin continued growth.

Strategic review and outlook

• Heightened interest from external parties led to a board-initiated strategic review, with all options being considered to maximize shareholder value.

• The review process, advised by Goldman, is expected to conclude within months, not years.

• Confidence remains in the standalone strategy, but alternatives are being evaluated.

Financial performance and guidance

• Q1 performance met expectations, but guidance was lowered due to reduced customer forecasts for electrophysiology (EP) products after rapid PFA adoption.

• Inventory adjustments by multiple customers are seen as short-term, not due to share loss or insourcing.

• Over half of the guidance reduction is attributed to EP, with additional risk adjustments applied.